Funding Rounds
Draupnir Bio Unknown (2019, $33M)
Draupnir BioDeveloper of oral, small molecule degrades for extracellular disease-causing proteins.
Summary
Stage: Unknown
Raised Amount: $33.21M
Raised Date: 2019-01-01
Stage: Unknown
Raised Amount: $33.21M
Raised Date: 2019-01-01